The Role of Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists in the Prevention and Treatment of Diabetic Kidney Disease: Insights from the AMPLITUDE-O Trial.
The Role of Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists in the Prevention and Treatment of Diabetic Kidney Disease: Insights from the AMPLITUDE-O Trial.
复制标题
胰高血糖素样肽 1 (GLP-1) 受体激动剂在预防和治疗糖尿病肾病中的作用：来自 AMPLITUDE-O 试验的见解。
DOI：
10.2215/cjn.00020122
复制
发表时间：
2022
期刊：
影响因子：
--
通讯作者：
Bjornstad,Petter
中科院分区：
文献类型：
--
作者：
Tommerdahl,KalieL;Kendrick,Jessica;Bjornstad,Petter
